GEFRIERGETROCKNETE ARIPIPRAZOLFORMULIERUNG

Patent europeic · EP2717859 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2717859
Numer da la dumonda
EP12731189
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-06-2012
Publitgà
16-04-2014
Concedì
31-08-2016
La protecziun finescha il pli tard
06-06-2032
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 9/16 (2006.01)
A61K 9/19 (2006.01)
Prioritad
US 201161494088 P 07.06.2011
Dumonda PCT
PCT/JP2012/065180 07.06.2012
Publicaziun PCT
WO2012/169662 13.12.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  7. 22-09-2021

    Midada

    Published in Swissreg on 22.09.2021

  8. 31-08-2016

    Concedì

    Published in Swissreg on 31.08.2016

Partidas

Possessur

Otsuka Pharmaceutical Co., Ltd.

9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP

Inventur

HIRAOKA, Shogo

Osaka-shi Osaka 541-0045, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.